Compare AMPL & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPL | BLFS |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2013 |
| Metric | AMPL | BLFS |
|---|---|---|
| Price | $7.51 | $22.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | $13.50 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 2.9M | 391.5K |
| Earning Date | 05-20-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.84 | ★ 77.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $343,214,000.00 | $96,214,000.00 |
| Revenue This Year | $15.94 | $17.74 |
| Revenue Next Year | $14.98 | $21.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 14.68 | ★ 16.97 |
| 52 Week Low | $6.00 | $19.15 |
| 52 Week High | $14.27 | $29.57 |
| Indicator | AMPL | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 46.14 |
| Support Level | $6.00 | $20.54 |
| Resistance Level | $7.74 | $23.00 |
| Average True Range (ATR) | 0.58 | 0.95 |
| MACD | 0.19 | 0.15 |
| Stochastic Oscillator | 87.93 | 29.21 |
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.